Cross John Harry III - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 6, 2023, Cross John Harry III's relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Officer (Chief Financial Officer), and currently has 23,927 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SONN insiders.
Data Source: SEC.
Cross John Harry III - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 7, 2023 | F -- (Common Stock) | 1960 | 1.06 | 23927 |